Avivagen Inc. is a development-stage biotechnology company. The Company is focused on bringing forward products based on its OxC-Beta (oxidized carotenoid) technology, to assist in optimizing health and feed animals. The Company is developing OxC-Beta as a non-antibiotic alternative feed additive for promoting health and productivity. OxC-Beta, is obtained via spontaneous, full oxidation of Beta-carotene. Its Vivamune consists of packages of 30 chews in two sizes for dogs and one for cats. Health Chews, Its Oximunol Chewables and Vivamune Health Chews contain mixtures of carotenoids and carotenoid oxidation products.